Cardiovascular Advances in Research and Opportunities Legacy Act

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 15 April 2021

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)

   Source: IntroReferral

2. 15 April 2021

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 15 April 2021 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 15 April 2021

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 15 April 2021

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 15 April 2021

  Open at official source

Sponsors

• Mitch McConnell · R · Sponsor
• Kyrsten Sinema · D · Sponsor
• Steve Daines · R · Cosponsor
• · sshr00 · Standing

Related records

• related to → Cardiovascular Advances in Research and Opportunities Legacy Act